TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T94627	Solute carrier family 28 member 2	D0TS1Z	Floxuridine	Approved	5790	C9H11FN2O5	246.19	C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O	IC50 > 1000000 nM	Non binder
T94627	Solute carrier family 28 member 2	D00YSJ	Tecadenoson	Discontinued in Phase 3	158795	C14H19N5O5	337.33	C1COC[C@@H]1NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O	Ki = 231000 nM	Non binder
T94627	Solute carrier family 28 member 2	B7A8EH	7,8,3'-Trihydroxyflavone	Investigative	676310	C15H10O5	270.24	C1=CC(=CC(=C1)O)C2=CC(=O)C3=C(O2)C(=C(C=C3)O)O	IC50 > 1000000 nM	Non binder
T94627	Solute carrier family 28 member 2	BB3AI2	Adenosine, 8-[(3-phenylpropyl)amino]-	Investigative	59035027	C19H24N6O4	400.4	C1=CC=C(C=C1)CCCNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 = 536000 nM	Non binder
T94627	Solute carrier family 28 member 2	BLM89I	CID 54553601	Investigative	54553601	C16H18N6O4	358.35	C1=CC=C(C=C1)NC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 = 289000 nM	Non binder
T94627	Solute carrier family 28 member 2	BS9N8J	CID 59034940	Investigative	59034940	C18H22N6O4	386.4	C1=CC=C(C=C1)CCNC2=NC3=C(N=CN=C3N2[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N	IC50 = 233000 nM	Non binder